PHARMABEES vs HIKAL: Stock Comparison
Head-to-head financial and trading comparison between PHARMABEES (PHARMABEES) and Hikal Limited (HIKAL) in the Cross-Sector Peers sector.
PHARMABEES
NSE: PHARMABEESHIKAL
NSE: HIKALKey Metrics Comparison Table
| Metric | PHARMABEES | HIKAL | Edge / Winner |
|---|---|---|---|
| Current Market Price (CMP) | ₹26.72 | ₹213.66 | — |
| 1-Year Price Return | +16.07% | +13.41% | PHARMABEES (2.66% higher) |
| 52-Week High | ₹27.89 | ₹246.01 | — |
| 52-Week Low | ₹23.00 | ₹176.15 | — |
| 30-Day Annualized Volatility | 14.23% | 83.94% | PHARMABEES (Steadier) |
| 30-Day Average Daily Volume | 4,400,662 | 2,681,728 | PHARMABEES (Higher Liquidity) |
| Statutory Cost to Trade ₹1 Lakh | ₹118.50 | ₹118.50 | Identical statutory tariff |
Frequently Asked Questions
Between PHARMABEES and HIKAL, which stock gave better returns over the last year?
PHARMABEES has outperformed HIKAL over the past 12 months with a gain of 16.07% compared to 13.41%.
Which stock is less volatile: PHARMABEES or HIKAL?
PHARMABEES demonstrated lower price volatility (14.23% annualized) compared to HIKAL (83.94%). Lower volatility generally indicates steadier price action during market downturns.
What is the statutory cost to buy ₹1,00,000 of PHARMABEES vs HIKAL?
Statutory exchange and government charges (STT, NSE turnover fees, SEBI fee, Stamp duty, and GST) are identical for delivery purchases of equal rupee value across both stocks, totaling approximately ₹118.50 on discount brokers offering zero delivery brokerage (like Zerodha or Dhan).
Are PHARMABEES and HIKAL direct sector competitors?
Yes, both companies operate within the Cross-Sector Peers sector in India and are actively tracked as sector peers by institutional and retail market participants.